APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autologous Immune Cell Storage

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Autologous Immune Cell Storage Market Outlook and Growth Opportunities 2026

1 May 2026193 pages

Choose your research edition.

Industry ResearchAutologous Immune Cell Storage Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Autologous Immune Cell Storage Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Autologous Immune Cell Storage Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autologous Immune Cell Storage Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Autologous Immune Cell Storage Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Autologous Immune Cell Storage market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autologous Immune Cell Storage is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Autologous Immune Cell Storage market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Autologous Immune Cell Storage market include HealthBanks, Aeterna Health, Cell Vault, Redermis, Innovita Research, STEMCELL, Enhance Biomedical, Immunaeon and Miracell, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Autologous Immune Cell Storage market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Autologous Immune Cell Storage and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Autologous Immune Cell Storage revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Autologous Immune Cell Storage market.

Autologous Immune Cell Storage Segment by Company

HealthBanks

Aeterna Health

Cell Vault

Redermis

Innovita Research

STEMCELL

Enhance Biomedical

Immunaeon

Miracell

VCANBIO Cell and Gene Engineering Corp., Ltd.

Shenzhen Beike Bio-Technology Co.,Ltd

Beijing Health and Biotech Group Corp. Ltd.

Shanghai Cell Therapy Group Co. Ltd.

BGI Genomics

Shanghai Saiyao Biotechnology Co., Ltd.

Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.

Autologous Immune Cell Storage Segment by Type

Lymphocyte Storage

Hematopoietic Stem Cell Storage

Autologous Immune Cell Storage Segment by Application

Treat Leukemia and Blood-Related Diseases

Immune System Modulation

Stem Cell Transplant

Autologous Immune Cell Storage Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Autologous Immune Cell Storage status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Autologous Immune Cell Storage key companies, revenue, market share, and recent developments.

3. To split the Autologous Immune Cell Storage breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Autologous Immune Cell Storage market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Autologous Immune Cell Storage significant trends, drivers, influence factors in global and regions.

6. To analyze Autologous Immune Cell Storage competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autologous Immune Cell Storage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autologous Immune Cell Storage and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autologous Immune Cell Storage.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Autologous Immune Cell Storage industry.

Chapter 3: Detailed analysis of Autologous Immune Cell Storage company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Autologous Immune Cell Storage in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Autologous Immune Cell Storage in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Autologous Immune Cell Storage Industry Trends Table 2. Autologous Immune Cell Storage Industry Drivers Table 3. Autologous Immune Cell Storage Industry Opportunities and Challenges Table 4. Autologous Immune Cell Storage Industry Restraints Table 5. Global Autologous Immune Cell Storage Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Autologous Immune Cell Storage Revenue Share by Company (2021-2026) Table 7. Global Autologous Immune Cell Storage Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Autologous Immune Cell Storage Key Company Manufacturing Base & Headquarters Table 9. Global Autologous Immune Cell Storage Company, Product Type & Application Table 10. Global Autologous Immune Cell Storage Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Autologous Immune Cell Storage by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Lymphocyte Storage Table 15. Significant Companies of Hematopoietic Stem Cell Storage Table 16. Global Autologous Immune Cell Storage Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Autologous Immune Cell Storage Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Autologous Immune Cell Storage Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Autologous Immune Cell Storage Sales Value Share by Type (2021-2026) Table 20. Global Autologous Immune Cell Storage Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Treat Leukemia and Blood-Related Diseases Table 22. Significant Companies of Immune System Modulation Table 23. Significant Companies of Stem Cell Transplant Table 24. Global Autologous Immune Cell Storage Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Autologous Immune Cell Storage Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Autologous Immune Cell Storage Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Autologous Immune Cell Storage Sales Value Share by Application (2021-2026) Table 28. Global Autologous Immune Cell Storage Sales Value Share by Application (2027-2032) Table 29. Global Autologous Immune Cell Storage Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Autologous Immune Cell Storage Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Autologous Immune Cell Storage Sales Value Share by Region (2021-2026) Table 32. Global Autologous Immune Cell Storage Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Autologous Immune Cell Storage Sales Value Share by Region (2027-2032) Table 34. Global Autologous Immune Cell Storage Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Autologous Immune Cell Storage Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Autologous Immune Cell Storage Sales Value Market Share by Country (2021-2026) Table 37. Global Autologous Immune Cell Storage Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Autologous Immune Cell Storage Sales Value Market Share by Country (2027-2032) Table 39. HealthBanks Company Information Table 40. HealthBanks Business Overview Table 41. HealthBanks Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. HealthBanks Autologous Immune Cell Storage Product Portfolio Table 43. HealthBanks Recent Development Table 44. Aeterna Health Company Information Table 45. Aeterna Health Business Overview Table 46. Aeterna Health Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Aeterna Health Autologous Immune Cell Storage Product Portfolio Table 48. Aeterna Health Recent Development Table 49. Cell Vault Company Information Table 50. Cell Vault Business Overview Table 51. Cell Vault Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Cell Vault Autologous Immune Cell Storage Product Portfolio Table 53. Cell Vault Recent Development Table 54. Redermis Company Information Table 55. Redermis Business Overview Table 56. Redermis Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Redermis Autologous Immune Cell Storage Product Portfolio Table 58. Redermis Recent Development Table 59. Innovita Research Company Information Table 60. Innovita Research Business Overview Table 61. Innovita Research Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Innovita Research Autologous Immune Cell Storage Product Portfolio Table 63. Innovita Research Recent Development Table 64. STEMCELL Company Information Table 65. STEMCELL Business Overview Table 66. STEMCELL Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. STEMCELL Autologous Immune Cell Storage Product Portfolio Table 68. STEMCELL Recent Development Table 69. Enhance Biomedical Company Information Table 70. Enhance Biomedical Business Overview Table 71. Enhance Biomedical Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Enhance Biomedical Autologous Immune Cell Storage Product Portfolio Table 73. Enhance Biomedical Recent Development Table 74. Immunaeon Company Information Table 75. Immunaeon Business Overview Table 76. Immunaeon Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Immunaeon Autologous Immune Cell Storage Product Portfolio Table 78. Immunaeon Recent Development Table 79. Miracell Company Information Table 80. Miracell Business Overview Table 81. Miracell Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Miracell Autologous Immune Cell Storage Product Portfolio Table 83. Miracell Recent Development Table 84. VCANBIO Cell and Gene Engineering Corp., Ltd. Company Information Table 85. VCANBIO Cell and Gene Engineering Corp., Ltd. Business Overview Table 86. VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Product Portfolio Table 88. VCANBIO Cell and Gene Engineering Corp., Ltd. Recent Development Table 89. Shenzhen Beike Bio-Technology Co.,Ltd Company Information Table 90. Shenzhen Beike Bio-Technology Co.,Ltd Business Overview Table 91. Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Product Portfolio Table 93. Shenzhen Beike Bio-Technology Co.,Ltd Recent Development Table 94. Beijing Health and Biotech Group Corp. Ltd. Company Information Table 95. Beijing Health and Biotech Group Corp. Ltd. Business Overview Table 96. Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Product Portfolio Table 98. Beijing Health and Biotech Group Corp. Ltd. Recent Development Table 99. Shanghai Cell Therapy Group Co. Ltd. Company Information Table 100. Shanghai Cell Therapy Group Co. Ltd. Business Overview Table 101. Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Product Portfolio Table 103. Shanghai Cell Therapy Group Co. Ltd. Recent Development Table 104. BGI Genomics Company Information Table 105. BGI Genomics Business Overview Table 106. BGI Genomics Autologous Immune Cell Storage Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. BGI Genomics Autologous Immune Cell Storage Product Portfolio Table 108. BGI Genomics Recent Development Table 109. Shanghai Saiyao Biotechnology Co., Ltd. Company Information Table 110. Shanghai Saiyao Biotechnology Co., Ltd. Business Overview Table 111. Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Product Portfolio Table 113. Shanghai Saiyao Biotechnology Co., Ltd. Recent Development Table 114. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Company Information Table 115. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Business Overview Table 116. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Product Portfolio Table 118. Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Recent Development Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Autologous Immune Cell Storage Product Image Figure 2. Global Autologous Immune Cell Storage Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autologous Immune Cell Storage Market Size (2021-2032) & (US$ Million) Figure 4. Global Autologous Immune Cell Storage Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Lymphocyte Storage Image Figure 8. Hematopoietic Stem Cell Storage Image Figure 9. Global Autologous Immune Cell Storage Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Autologous Immune Cell Storage Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Autologous Immune Cell Storage Sales Value Share by Type (2021-2032) Figure 12. Treat Leukemia and Blood-Related Diseases Image Figure 13. Immune System Modulation Image Figure 14. Stem Cell Transplant Image Figure 15. Global Autologous Immune Cell Storage Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Autologous Immune Cell Storage Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Autologous Immune Cell Storage Sales Value Share by Application (2021-2032) Figure 18. Global Autologous Immune Cell Storage Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Autologous Immune Cell Storage Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Autologous Immune Cell Storage Sales Value (2021-2032) & (US$ Million) Figure 21. North America Autologous Immune Cell Storage Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Autologous Immune Cell Storage Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Autologous Immune Cell Storage Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Autologous Immune Cell Storage Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Autologous Immune Cell Storage Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Autologous Immune Cell Storage Sales Value (2021-2032) & (US$ Million) Figure 27. South America Autologous Immune Cell Storage Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Autologous Immune Cell Storage Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Autologous Immune Cell Storage Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Lymphocyte Storage
  • Hematopoietic Stem Cell Storage
Applications
  • Treat Leukemia and Blood-Related Diseases
  • Immune System Modulation
  • Stem Cell Transplant
Companies covered
  • HealthBanks
  • Aeterna Health
  • Cell Vault
  • Redermis
  • Innovita Research
  • STEMCELL
  • Enhance Biomedical
  • Immunaeon
  • Miracell
  • VCANBIO Cell and Gene Engineering Corp., Ltd.
  • Shenzhen Beike Bio-Technology Co.,Ltd
  • Beijing Health and Biotech Group Corp. Ltd.
  • Shanghai Cell Therapy Group Co. Ltd.
  • BGI Genomics
  • Shanghai Saiyao Biotechnology Co., Ltd.
  • Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Autologous Immune Cell Storage Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Autologous Immune Cell Storage Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Autologous Immune Cell Storage Market Dynamics
  1. 2.1 Autologous Immune Cell Storage Industry Trends
  2. 2.2 Autologous Immune Cell Storage Industry Drivers
  3. 2.3 Autologous Immune Cell Storage Industry Opportunities and Challenges
  4. 2.4 Autologous Immune Cell Storage Industry Restraints
3 Autologous Immune Cell Storage Market by Company
  1. 3.1 Global Autologous Immune Cell Storage Company Revenue Ranking in 2025
  2. 3.2 Global Autologous Immune Cell Storage Revenue by Company (2021-2026)
  3. 3.3 Global Autologous Immune Cell Storage Company Ranking (2024-2026)
  4. 3.4 Global Autologous Immune Cell Storage Company Manufacturing Base and Headquarters
  5. 3.5 Global Autologous Immune Cell Storage Company Product Type and Application
  6. 3.6 Global Autologous Immune Cell Storage Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Autologous Immune Cell Storage Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Autologous Immune Cell Storage Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Autologous Immune Cell Storage Market by Type
  1. 4.1 Autologous Immune Cell Storage Type Introduction
  2. 4.1.1 Lymphocyte Storage
  3. 4.1.2 Hematopoietic Stem Cell Storage
  4. 4.2 Global Autologous Immune Cell Storage Sales Value by Type
  5. 4.2.1 Global Autologous Immune Cell Storage Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Autologous Immune Cell Storage Sales Value by Type (2021-2032)
  7. 4.2.3 Global Autologous Immune Cell Storage Sales Value Share by Type (2021-2032)
5 Autologous Immune Cell Storage Market by Application
  1. 5.1 Autologous Immune Cell Storage Application Introduction
  2. 5.1.1 Treat Leukemia and Blood-Related Diseases
  3. 5.1.2 Immune System Modulation
  4. 5.1.3 Stem Cell Transplant
  5. 5.2 Global Autologous Immune Cell Storage Sales Value by Application
  6. 5.2.1 Global Autologous Immune Cell Storage Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Autologous Immune Cell Storage Sales Value by Application (2021-2032)
  8. 5.2.3 Global Autologous Immune Cell Storage Sales Value Share by Application (2021-2032)
6 Autologous Immune Cell Storage Regional Value Analysis
  1. 6.1 Global Autologous Immune Cell Storage Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Autologous Immune Cell Storage Sales Value by Region (2021-2032)
  3. 6.2.1 Global Autologous Immune Cell Storage Sales Value by Region: 2021-2026
  4. 6.2.2 Global Autologous Immune Cell Storage Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Autologous Immune Cell Storage Sales Value (2021-2032)
  7. 6.3.2 North America Autologous Immune Cell Storage Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Autologous Immune Cell Storage Sales Value (2021-2032)
  10. 6.4.2 Europe Autologous Immune Cell Storage Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Autologous Immune Cell Storage Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Autologous Immune Cell Storage Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Autologous Immune Cell Storage Sales Value (2021-2032)
  16. 6.6.2 South America Autologous Immune Cell Storage Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Autologous Immune Cell Storage Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Autologous Immune Cell Storage Sales Value Share by Country, 2025 VS 2032
7 Autologous Immune Cell Storage Country-level Value Analysis
  1. 7.1 Global Autologous Immune Cell Storage Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Autologous Immune Cell Storage Sales Value by Country (2021-2032)
  3. 7.2.1 Global Autologous Immune Cell Storage Sales Value by Country (2021-2026)
  4. 7.2.2 Global Autologous Immune Cell Storage Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Autologous Immune Cell Storage Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Autologous Immune Cell Storage Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Autologous Immune Cell Storage Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 HealthBanks
  2. 8.1.1 HealthBanks Company Information
  3. 8.1.2 HealthBanks Business Overview
  4. 8.1.3 HealthBanks Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  5. 8.1.4 HealthBanks Autologous Immune Cell Storage Product Portfolio
  6. 8.1.5 HealthBanks Recent Developments
  7. 8.2 Aeterna Health
  8. 8.2.1 Aeterna Health Company Information
  9. 8.2.2 Aeterna Health Business Overview
  10. 8.2.3 Aeterna Health Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aeterna Health Autologous Immune Cell Storage Product Portfolio
  12. 8.2.5 Aeterna Health Recent Developments
  13. 8.3 Cell Vault
  14. 8.3.1 Cell Vault Company Information
  15. 8.3.2 Cell Vault Business Overview
  16. 8.3.3 Cell Vault Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cell Vault Autologous Immune Cell Storage Product Portfolio
  18. 8.3.5 Cell Vault Recent Developments
  19. 8.4 Redermis
  20. 8.4.1 Redermis Company Information
  21. 8.4.2 Redermis Business Overview
  22. 8.4.3 Redermis Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Redermis Autologous Immune Cell Storage Product Portfolio
  24. 8.4.5 Redermis Recent Developments
  25. 8.5 Innovita Research
  26. 8.5.1 Innovita Research Company Information
  27. 8.5.2 Innovita Research Business Overview
  28. 8.5.3 Innovita Research Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Innovita Research Autologous Immune Cell Storage Product Portfolio
  30. 8.5.5 Innovita Research Recent Developments
  31. 8.6 STEMCELL
  32. 8.6.1 STEMCELL Company Information
  33. 8.6.2 STEMCELL Business Overview
  34. 8.6.3 STEMCELL Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  35. 8.6.4 STEMCELL Autologous Immune Cell Storage Product Portfolio
  36. 8.6.5 STEMCELL Recent Developments
  37. 8.7 Enhance Biomedical
  38. 8.7.1 Enhance Biomedical Company Information
  39. 8.7.2 Enhance Biomedical Business Overview
  40. 8.7.3 Enhance Biomedical Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Enhance Biomedical Autologous Immune Cell Storage Product Portfolio
  42. 8.7.5 Enhance Biomedical Recent Developments
  43. 8.8 Immunaeon
  44. 8.8.1 Immunaeon Company Information
  45. 8.8.2 Immunaeon Business Overview
  46. 8.8.3 Immunaeon Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Immunaeon Autologous Immune Cell Storage Product Portfolio
  48. 8.8.5 Immunaeon Recent Developments
  49. 8.9 Miracell
  50. 8.9.1 Miracell Company Information
  51. 8.9.2 Miracell Business Overview
  52. 8.9.3 Miracell Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Miracell Autologous Immune Cell Storage Product Portfolio
  54. 8.9.5 Miracell Recent Developments
  55. 8.10 VCANBIO Cell and Gene Engineering Corp., Ltd.
  56. 8.10.1 VCANBIO Cell and Gene Engineering Corp., Ltd. Company Information
  57. 8.10.2 VCANBIO Cell and Gene Engineering Corp., Ltd. Business Overview
  58. 8.10.3 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  59. 8.10.4 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Product Portfolio
  60. 8.10.5 VCANBIO Cell and Gene Engineering Corp., Ltd. Recent Developments
  61. 8.11 Shenzhen Beike Bio-Technology Co.,Ltd
  62. 8.11.1 Shenzhen Beike Bio-Technology Co.,Ltd Company Information
  63. 8.11.2 Shenzhen Beike Bio-Technology Co.,Ltd Business Overview
  64. 8.11.3 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Product Portfolio
  66. 8.11.5 Shenzhen Beike Bio-Technology Co.,Ltd Recent Developments
  67. 8.12 Beijing Health and Biotech Group Corp. Ltd.
  68. 8.12.1 Beijing Health and Biotech Group Corp. Ltd. Company Information
  69. 8.12.2 Beijing Health and Biotech Group Corp. Ltd. Business Overview
  70. 8.12.3 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Product Portfolio
  72. 8.12.5 Beijing Health and Biotech Group Corp. Ltd. Recent Developments
  73. 8.13 Shanghai Cell Therapy Group Co. Ltd.
  74. 8.13.1 Shanghai Cell Therapy Group Co. Ltd. Company Information
  75. 8.13.2 Shanghai Cell Therapy Group Co. Ltd. Business Overview
  76. 8.13.3 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Product Portfolio
  78. 8.13.5 Shanghai Cell Therapy Group Co. Ltd. Recent Developments
  79. 8.14 BGI Genomics
  80. 8.14.1 BGI Genomics Company Information
  81. 8.14.2 BGI Genomics Business Overview
  82. 8.14.3 BGI Genomics Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BGI Genomics Autologous Immune Cell Storage Product Portfolio
  84. 8.14.5 BGI Genomics Recent Developments
  85. 8.15 Shanghai Saiyao Biotechnology Co., Ltd.
  86. 8.15.1 Shanghai Saiyao Biotechnology Co., Ltd. Company Information
  87. 8.15.2 Shanghai Saiyao Biotechnology Co., Ltd. Business Overview
  88. 8.15.3 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Product Portfolio
  90. 8.15.5 Shanghai Saiyao Biotechnology Co., Ltd. Recent Developments
  91. 8.16 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
  92. 8.16.1 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Company Information
  93. 8.16.2 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Business Overview
  94. 8.16.3 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Product Portfolio
  96. 8.16.5 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst